{"id":99161,"date":"2024-10-01T11:36:07","date_gmt":"2024-10-01T11:36:07","guid":{"rendered":"https:\/\/kamucalisani.net\/?p=99161"},"modified":"2024-10-01T11:36:07","modified_gmt":"2024-10-01T11:36:07","slug":"sizofreni-icin-30-yil-sonra-ilk-kez-yeni-bir-ilac-onaylandi","status":"publish","type":"post","link":"https:\/\/kamucalisani.net\/index.php\/2024\/10\/01\/sizofreni-icin-30-yil-sonra-ilk-kez-yeni-bir-ilac-onaylandi\/","title":{"rendered":"\u015eizofreni i\u00e7in 30 y\u0131l sonra ilk kez yeni bir ila\u00e7 onayland\u0131"},"content":{"rendered":"<p><figure> <span> <img decoding=\"async\" src=\"https:\/\/kamucalisani.net\/wp-content\/uploads\/2024\/10\/sizofreni-icin-30-yil-sonra-ilk-kez-yeni-bir-ilac-onaylandi-0-xEBvjNUY.jpg\"\/> <\/span> <strong>ABD G\u0131da ve \u0130la\u00e7 Dairesi<\/strong> (FDA), <strong>\u015fizofreni<\/strong> tedavisinde 30 y\u0131ldan uzun bir s\u00fcredir ilk kez yeni bir ilac\u0131 onaylad\u0131. <strong>Cobenfy<\/strong> ad\u0131 verilen bu ila\u00e7, Bristol Myers Squibb taraf\u0131ndan geli\u015ftirildi ve iki farkl\u0131 ilac\u0131 (xanomeline ve trospium chloride) birle\u015ftirerek \u015fizofreni semptomlar\u0131n\u0131n kontrol alt\u0131na al\u0131nmas\u0131na yard\u0131mc\u0131 oluyor. Cobenfy, g\u00fcnde iki kez al\u0131nan bir hap formunda sunulacak. <\/figure>\n<p><b>\u015eizofreni tedavisi i\u00e7in yeni ila\u00e7<\/b><\/p>\n<p>\u0130lac\u0131n onaylanmas\u0131n\u0131n ard\u0131ndan yap\u0131lan a\u00e7\u0131klamalarda, FDA\u2019n\u0131n N\u00f6robilim Ofisi, Psikiyatri B\u00f6l\u00fcm\u00fc Direkt\u00f6r\u00fc Dr. Tiffany Farchione, \u015fizofreninin d\u00fcnya genelinde \u00f6nde gelen engellilik nedenlerinden biri oldu\u011funu vurgulad\u0131. Farchione, \u201c<em>Bu ila\u00e7 \u015fizofreni tedavisine on y\u0131llard\u0131r ilk kez yeni bir yakla\u015f\u0131m getiriyor. Bu onay, \u015fizofreni hastalar\u0131na daha \u00f6nce verilen antipsikotik ila\u00e7lara yeni bir alternatif sunuyor.\u201d<\/em><\/p>\n<figure> <span> <img decoding=\"async\" src=\"https:\/\/kamucalisani.net\/wp-content\/uploads\/2024\/10\/sizofreni-icin-30-yil-sonra-ilk-kez-yeni-bir-ilac-onaylandi-1-cgy9a6C6.jpg\"\/> <\/span> Cobenfy, xanomelin ve trospium chloride (veya trospiyum klor\u00fcr) adl\u0131 iki etken maddeyi i\u00e7eriyor. Klinik denemelerde bu kombinasyonun, \u015fizofreni hastalar\u0131nda hal\u00fcsinasyonlar, sanr\u0131lar ve d\u00fczensiz d\u00fc\u015f\u00fcncegibi <strong>yayg\u0131n semptomlar\u0131n y\u00f6netilmesine yard\u0131mc\u0131 <\/strong>oldu\u011fu g\u00f6sterildi. \u015eizofreni tedavisinde kullan\u0131lan geleneksel ila\u00e7lar, genellikle beyin kimyasallar\u0131ndan dopamini hedef al\u0131rken, Cobenfy bunun yerine haf\u0131zaya, \u00f6\u011frenmeye ve dikkati toplamaya yard\u0131mc\u0131 olan bir ba\u015fka beyin kimyasal\u0131 olan <strong>asetilkolini hedef al\u0131yor.<\/strong> Bu yeni mekanizman\u0131n, \u015fizofreni tedavisinde yayg\u0131n olankilo al\u0131m\u0131, uyuklama ve hareket bozukluklar\u0131 gibi<strong> yan etkilerin azalt\u0131lmas\u0131na katk\u0131<\/strong> sa\u011flayabilece\u011fi belirtiliyor. <\/figure>\n<p>Cobenfy\u2019nin klinik denemeleri s\u0131ras\u0131nda, yan etkiler nedeniyle ilac\u0131 b\u0131rakan hastalar\u0131n oran\u0131n\u0131n yaln\u0131zca y\u00fczde 6 oldu\u011fu bildirildi. Bu oran geleneksel ila\u00e7larda y\u00fczde 20-30\u2019a kadar \u00e7\u0131kabiliyor. Bununla birlikte, Cobenfy\u2019nin de baz\u0131 yan etkileri mevcut. FDA\u2019ya g\u00f6re, en yayg\u0131n g\u00f6r\u00fclen yan etkiler aras\u0131nda mide bulant\u0131s\u0131, haz\u0131ms\u0131zl\u0131k, kab\u0131zl\u0131k, kusma, y\u00fcksek tansiyon, kar\u0131n a\u011fr\u0131s\u0131, ishal, artan kalp at\u0131\u015f h\u0131z\u0131 ve ba\u015f d\u00f6nmesi bulunuyor. Ancak uzmanlar, \u00f6zellikle <strong>geleneksel ila\u00e7lar\u0131n yan etkilerine dayanamayan hastalar\u0131n Cobenfy\u2019den b\u00fcy\u00fck fayda sa\u011flayabilece\u011fini<\/strong> ifade ediyor.<\/p>\n<p>D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc\u2019ne (WHO) g\u00f6re, d\u00fcnya genelinde yakla\u015f\u0131k 24 milyon insan \u015fizofreni ile ya\u015f\u0131yor. Bu, her 300 ki\u015fiden birinin bu kronik ve zorlu hastal\u0131\u011f\u0131n etkilerini ya\u015fad\u0131\u011f\u0131 anlam\u0131na geliyor. Hastal\u0131k genellikle ergenlik d\u00f6nemi sonlar\u0131nda ya da erken yeti\u015fkinlik d\u00f6neminde ba\u015fl\u0131yor ve uygun \u015fekilde tedavi edilmedi\u011finde hayat boyu s\u00fcren engelliliklere yol a\u00e7abiliyor.<\/p>\n\n<p>Kaynak\u00a0 :\u00a0<span style=\"background-color: rgb(255, 249, 236); color: rgb(55, 58, 60); font-size: 14px;\">https:\/\/www.donanimhaber.com\/sizofreni-icin-30-yil-sonra-ilk-kez-yeni-bir-ilac-onaylandi&#8211;182527<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>ABD G\u0131da ve \u0130la\u00e7 Dairesi (FDA), \u015fizofreni tedavisinde 30 y\u0131ldan uzun bir s\u00fcredir ilk kez yeni bir ilac\u0131 onaylad\u0131. Cobenfy ad\u0131 verilen bu ila\u00e7, Bristol Myers Squibb taraf\u0131ndan geli\u015ftirildi ve iki farkl\u0131 ilac\u0131 (xanomeline ve trospium chloride &#8230;<\/p>\n","protected":false},"author":1,"featured_media":99162,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8],"tags":[6419,6420,4582,6421,6422],"class_list":["post-99161","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-teknoloji","tag-cobenfy","tag-etkiler","tag-ilac","tag-sizofreni","tag-sizofreni-tedavisi"],"_links":{"self":[{"href":"https:\/\/kamucalisani.net\/index.php\/wp-json\/wp\/v2\/posts\/99161","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kamucalisani.net\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kamucalisani.net\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kamucalisani.net\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kamucalisani.net\/index.php\/wp-json\/wp\/v2\/comments?post=99161"}],"version-history":[{"count":1,"href":"https:\/\/kamucalisani.net\/index.php\/wp-json\/wp\/v2\/posts\/99161\/revisions"}],"predecessor-version":[{"id":99165,"href":"https:\/\/kamucalisani.net\/index.php\/wp-json\/wp\/v2\/posts\/99161\/revisions\/99165"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kamucalisani.net\/index.php\/wp-json\/wp\/v2\/media\/99162"}],"wp:attachment":[{"href":"https:\/\/kamucalisani.net\/index.php\/wp-json\/wp\/v2\/media?parent=99161"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kamucalisani.net\/index.php\/wp-json\/wp\/v2\/categories?post=99161"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kamucalisani.net\/index.php\/wp-json\/wp\/v2\/tags?post=99161"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}